Chirag Patel is a Nephrology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1550 N Northwest Hwy
Suite 303
Park Ridge, IL 600681411
Telephone
847-294-5160Provider last certified this registry record 22 Nov 2024.
Clinical trials
- Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours
Sponsor: Enhanced Medical
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Fresenius USA Marketing, Inc.Program year20251 payment
- Recor Medical IncProgram year20251 payment
- Travere Therapeutics, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
43.3%Beta blocker9.6%Metoprolol Succinate41%Carvedilol36%Metoprolol Tartrate11%Atenolol7%Sotalol3%Bisoprolol Fumarate2%Part D<11 patientsLoop diuretic7.7%Furosemide38%Bumetanide36%Torsemide26%Part D≥45 patients+ 14 more classes in this area
Nervous system
23.8%SSRI8.4%Escitalopram Oxalate42%Sertraline Hcl37%Trazodone Hcl13%Citalopram Hbr8%Part D<11 patientsGabapentinoids2.8%Gabapentin100%Part D≥33 patients+ 13 more classes in this area
Metabolism & gastrointestinal
12.8%Vitamin D3 Analog3%Calcitriol100%Part D≥44 patientsProton pump inhibitor2.8%Pantoprazole Sodium58%Omeprazole29%Esomeprazole Magnesium13%Part D<11 patients+ 10 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”